Abstract
Drug and gene delivery via nanoparticles across biological barriers such as the alveolar-capillary barrier of the lung constitutes an interesting and increasingly relevant field in nanomedicine. Nevertheless, potential hazardous effects of nanoparticles (NPs) as well as their cellular and systemic fate should be thoroughly examined. Hence, this study was designed to evaluate the effects of amorphous silica NPs (Sicastar) and (poly)organosiloxane NPs (AmOrSil) on the viability and the inflammatory response as well as on the cellular uptake mechanisms and fate in cells of the alveolar barrier. For this purpose, the alveolar epithelial cell line (NCI H441) and microvascular endothelial cell line (ISO-HAS-1) were used in an experimental set up resembling the alveolar-capillary barrier of the lung. In terms of IL-8 and sICAM Sicastar resulted in harmful effects at higher concentrations (60 μg/ml) in conventional monocultures but not in the coculture, whereas AmOrSil showed no significant effects. Immunofluorescence counterstaining of endosomal structures in NP-incubated cells showed no evidence for a clathrin- or caveolae-mediated uptake mechanism. However, NPs were enclosed in flotillin-1 and -2 marked vesicles in both cell types. Flotillins appear to play a role in cellular uptake or trafficking mechanisms of NPs and are discussed as indicators for clathrin- or caveolae-independent uptake mechanisms. In addition, we examined the transport of NPs across this in vitro model of the alveolar-capillary barrier forming a tight barrier with a transepithelial electrical resistance of 560 ± 8 Ω cm2. H441 in coculture with endothelial cells took up much less NPs compared to monocultures. Moreover, coculturing prevented the transport of NP from the epithelial compartment to the endothelial layer on the bottom of the filter insert. This supports the relevance of coculture models, which favour a differentiated and polarised epithelial layer as in vitro test systems for nanoparticle uptake.
Original language | English |
---|---|
Pages (from-to) | 275-287 |
Number of pages | 13 |
Journal | European Journal of Pharmaceutics and Biopharmaceutics |
Volume | 84 |
Issue number | 2 |
DOIs | |
State | Published - Jun 2013 |
Externally published | Yes |
Bibliographical note
Funding Information:The authors wish to thank Ms. Elke Hübsch and Ms Michaela Moisch for their excellent assistance with the cell culture and immunocytochemical studies. This study was supported by the DFG priority program SPP 1313 within the Cluster BIONEERS and also by the European Union, FP6 Project NanoBioPharmaceutics.
Funding
The authors wish to thank Ms. Elke Hübsch and Ms Michaela Moisch for their excellent assistance with the cell culture and immunocytochemical studies. This study was supported by the DFG priority program SPP 1313 within the Cluster BIONEERS and also by the European Union, FP6 Project NanoBioPharmaceutics.
Funders | Funder number |
---|---|
Sixth Framework Programme | |
European Commission | |
Deutsche Forschungsgemeinschaft |
Keywords
- Alveolar-capillary barrier
- Endocytosis
- Flotillin-1/-2-dependent uptake/trafficking
- NP uptake
- NP-transport
- Silica nanoparticles